Letter regarding Article, "Clinical outcomes and sustainability of using CYP2C19 genotype-guided antiplatelet therapy after percutaneous coronary intervention"

由 Aw JWX, Tan DSY, Goh LL
出版 2020

Switching of P2Y12 Inhibitors in Acute Coronary Syndromes

由 Leong WQ, Kim JH, Aw JWX, Tan DSY
出版 2020

Comparison of rivaroxaban concentrations between Asians and Caucasians and their correlation with PT/INR

由 Ng HOT, Goh JJN, Aw JWX, Lin YY, Fong AYY, Tiong LL, Tan D
出版 2020

CYP2C19 phenotype in South?East Asian Acute Coronary Syndrome patients and impact on major adverse cardiovascular events

由 Tan DS, Aw JWX, Winther M, Goh LL, Ong HY, Wee E, Liu J, Ho HK, J Clin Pharm Ther
出版 2020